0001971857-24-000412.txt : 20240617
0001971857-24-000412.hdr.sgml : 20240617
20240617134617
ACCESSION NUMBER: 0001971857-24-000412
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240617
DATE AS OF CHANGE: 20240617
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001720893
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821386754
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38410
FILM NUMBER: 241047668
BUSINESS ADDRESS:
STREET 1: 555 LONG WHARF DRIVE
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-643-8060
MAIL ADDRESS:
STREET 1: 555 LONG WHARF DRIVE
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Yocca Frank
CENTRAL INDEX KEY: 0001733272
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 780 EAST MAIN STREET
STREET 2: C/O BIOXCEL THERAPEUTICS, INC.
CITY: BRANFORD
STATE: CT
ZIP: 06405
144
1
primary_doc.xml
144
0001733272
XXXXXXXX
LIVE
0001720893
BioXcel Therapeutics, Inc.
001-38410
555 LONG WHARF DRIVE
NEW HAVEN
CT
06511
203-643-8060
Yocca Frank
Officer
Common
Merrill Lynch
500 Cummings Center
Suite 1600
Beverly
MA
01915
372
476.16
37530821
06/17/2024
NASDAQ
Common
06/14/2024
Restricted Stock Units
BioXcel Therapeutics
N
521
06/17/2024
Cash
Common
06/15/2024
Restricted Stock Units
BioXcel Therapeutics
N
562
06/17/2024
Cash
N
Frank Yocca
555 Long Wharf Drive
New Haven
CT
06511
Common
04/04/2024
1067
2803.48
06/17/2024
12/14/2023
Frank Yocca